CD8A and neoplasm: The tumor-infiltrating CD8+ T cell expression level in RGC was significantly higher following benign initial disease than following malignant initial disease (p=0.046), whereas the tumor-infiltrating expression of CD8, CD4, FoxP3, and CD20 was not directly relevance with RFS (Additional file 5).